# Core Patient-Reported Outcomes in Cancer Clinical Trials:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/core-patient-reported-outcomes-in-cancer-clinical-trials-guidance-for-industry/a5111d3d-2d0d-4753-9773-d2f2a25c85fb

> FDA guidance document: Core Patient-Reported Outcomes in Cancer Clinical Trials:  Guidance for Industry. Issue date: October 17, 2024. Get complete insights and analysis.

---

## Details

- Title: Core Patient-Reported Outcomes in Cancer Clinical Trials:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2024-10-17
- Comment Close Date: 2021-08-09
- Last Changed: 2024-10-17
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2020-D-2303">FDA-2020-D-2303</a>

## Related Documents

- [Real-Time Oncology Review (RTOR) :  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/real-time-oncology-review-rtor-guidance-for-industry/5d600007-ac00-4be9-8047-0a2e0cfaeca2)
- [Inclusion of Older Adults in Cancer Clinical Trials:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/inclusion-of-older-adults-in-cancer-clinical-trials-guidance-for-industry/58e758a2-a626-41ba-8346-44066b8cd50f)
- [Multiple Endpoints in Clinical Trials:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/multiple-endpoints-in-clinical-trials-guidance-for-industry/d08a7428-0534-4dad-83d9-37a60fc5fe62)